Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11898)
All Articles published online
|
May 14, 2012 (publication date) through Nov 9, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Drepper MD, Spahr L, Frossard JL. Clopidogrel and proton pump inhibitors - where do we stand in 2012? World J Gastroenterol 2012; 18(18): 2161-2171 [PMID: 22611308 DOI: 10.3748/wjg.v18.i18.2161] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i18/2161.htm |
| Number | Citing Articles |
| 1 |
Jingtao Chen, Patrick Brady. Gastroesophageal Reflux Disease. Gastroenterology Nursing 2019; 42(1): 20 doi: 10.1097/SGA.0000000000000359
|
| 2 |
Ana María Pello Lázaro, Carmen Cristóbal, Juan Antonio Franco-Peláez, Nieves Tarín, Álvaro Aceña, Rocío Carda, Ana Huelmos, María Luisa Martín-Mariscal, Jesús Fuentes-Antras, Juan Martínez-Millá, Joaquín Alonso, Óscar Lorenzo, Jesús Egido, Lorenzo López-Bescós, José Tuñón, Raffaele Bugiardini. Use of Proton-Pump Inhibitors Predicts Heart Failure and Death in Patients with Coronary Artery Disease. PLOS ONE 2017; 12(1): e0169826 doi: 10.1371/journal.pone.0169826
|
| 3 |
Md.Mohaimenul Islam, Tahmina N. Poly, Bruno A. Walther, Navneet K. Dubey, Dina N. Anggraini Ningrum, Syed-Abdul Shabbir, Yu-Chuan (Jack) Li. Adverse outcomes of long-term use of proton pump inhibitors: a systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology 2018; 30(12): 1395 doi: 10.1097/MEG.0000000000001198
|
| 4 |
Yusmiati Yusmiati, Dewi Muliaty. The Pharmacogenetics of Cytochrome P450 2C19 Enzymes - Effects on Clopidogrel and Proton Pump Inhibitors. The Indonesian Biomedical Journal 2014; 6(1): 33 doi: 10.18585/inabj.v6i1.41
|
| 5 |
Nikhil Kapil, Yvonne H. Datta, Naila Alakbarova, Eric Bershad, Magdy Selim, David S. Liebeskind, Ornina Bachour, Gundu H. R. Rao, Afshin A. Divani. Antiplatelet and Anticoagulant Therapies for Prevention of Ischemic Stroke. Clinical and Applied Thrombosis/Hemostasis 2017; 23(4): 301 doi: 10.1177/1076029616660762
|
| 6 |
Ingvild Aune Søraas, Hanne Baust Staurset, Lars Slørdal, Olav Spigset. Legemiddelinteraksjoner hos pasienter i sykehjem. Tidsskrift for Den norske legeforening 2014; 134(10): 1041 doi: 10.4045/tidsskr.13.1550
|
| 7 |
Walter N. Kernan, Bruce Ovbiagele, Henry R. Black, Dawn M. Bravata, Marc I. Chimowitz, Michael D. Ezekowitz, Margaret C. Fang, Marc Fisher, Karen L. Furie, Donald V. Heck, S. Claiborne (Clay) Johnston, Scott E. Kasner, Steven J. Kittner, Pamela H. Mitchell, Michael W. Rich, DeJuran Richardson, Lee H. Schwamm, John A. Wilson. Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack. Stroke 2014; 45(7): 2160 doi: 10.1161/STR.0000000000000024
|
| 8 |
Michael A. Serbin, Gregory F. Guzauskas, David L. Veenstra. Clopidogrel-Proton Pump Inhibitor Drug-Drug Interaction and Risk of Adverse Clinical Outcomes Among PCI-Treated ACS Patients: A Meta-analysis. Journal of Managed Care & Specialty Pharmacy 2016; 22(8): 939 doi: 10.18553/jmcp.2016.22.8.939
|
| 9 |
José María Remes-Troche, Sergio Sobrino-Cossío, Julio César Soto-Pérez, Oscar Teramoto-Matsubara, Miguel Morales-Arámbula, Antonio Orozco-Gamiz, José Luis Tamayo de la Cuesta, Gualberto Mateos. Efficacy, Safety, and Tolerability of Pantoprazole Magnesium in the Treatment of Reflux Symptoms in Patients with Gastroesophageal Reflux Disease (GERD): A Prospective, Multicenter, Post-Marketing Observational Study. Clinical Drug Investigation 2014; 34(2): 83 doi: 10.1007/s40261-013-0135-4
|
| 10 |
Catherine Marcucci, Neil B. Sandson. A Case Approach to Perioperative Drug-Drug Interactions. 2015; : 685 doi: 10.1007/978-1-4614-7495-1_152
|
| 11 |
Omer Allela. Explore Adverse Drug Reactions (ADRs) reporting by clinical and community pharmacists in Duhok, Kurdistan region- Iraq: hampered and perspective. Pharmacia 2022; 69(4): 1057 doi: 10.3897/pharmacia.69.e95691
|
| 12 |
Tomáš Bolek, Matej Samoš, Radoslava Šimonová, František Kovář, Marián Fedor, Peter Galajda, Ján Staško, Peter Kubisz, Marián Mokáň. Does Pantoprazole Affect the On-Treatment Platelet Reactivity in Patients With Acute STEMI Treated With ADP Receptor Blockers?—A Pilot Prospective Study. American Journal of Therapeutics 2017; 24(2): e162 doi: 10.1097/MJT.0000000000000454
|
| 13 |
Daniel L. Ballantine, Stephanie J. Fisquet, James R. Winearls, John F. Fraser. Use of acid suppression medications in postoperative cardiac surgical intensive care unit patients. Journal of Pharmacy Practice and Research 2014; 44(3): 108 doi: 10.1002/jppr.1010
|
| 14 |
A. Komosa, J. M. Siller-Matula, J. Kowal, M. Lesiak, A. Siniawski, M. Mączyński, M. Michalak, T. Mularek-Kubzdela, S. Grajek. Comparison of the antiplatelet effect of two clopidogrel bisulfate formulations: Plavix and generic-Egitromb. Platelets 2015; 26(1): 43 doi: 10.3109/09537104.2013.877581
|
| 15 |
Nishank Jain, Robert F. Reilly. Oral P2Y12 Receptor Inhibitors in Hemodialysis Patients Undergoing Percutaneous Coronary Interventions: Current Knowledge and Future Directions. Seminars in Dialysis 2016; 29(5): 374 doi: 10.1111/sdi.12484
|
| 16 |
Timothy P. Shiraev, Andrew Bullen. Proton Pump Inhibitors and Cardiovascular Events: A Systematic Review. Heart, Lung and Circulation 2018; 27(4): 443 doi: 10.1016/j.hlc.2017.10.020
|
| 17 |
Mohammed Jarrar, Shalini Behl, Ganiraju Manyam, Hany Ganah, Mohammed Nazir, Reem Nasab, Khaled Moustafa. Cytochrome allelic variants and clopidogrel metabolism in cardiovascular diseases therapy. Molecular Biology Reports 2016; 43(6): 473 doi: 10.1007/s11033-016-3983-1
|
| 18 |
Fanny Bonhomme, Pierre Fontana, Jean-Luc Reny. How to manage prasugrel and ticagrelor in daily practice. European Journal of Internal Medicine 2014; 25(3): 213 doi: 10.1016/j.ejim.2014.01.016
|
| 19 |
Ann Marie Canelas, Randal O. Dull. A Case Approach to Perioperative Drug-Drug Interactions. 2015; : 681 doi: 10.1007/978-1-4614-7495-1_151
|
| 20 |
Prashanth Porayette, David Flockhart, Sandeep K. Gupta. One Size Fits One: Pharmacogenetics in Gastroenterology. Clinical Gastroenterology and Hepatology 2014; 12(4): 565 doi: 10.1016/j.cgh.2014.01.035
|
| 21 |
Young Ho Shin, Hyun Sik Gong, Goo Hyun Baek. Lower Trabecular Bone Score is Associated With the Use of Proton Pump Inhibitors. Journal of Clinical Densitometry 2019; 22(2): 236 doi: 10.1016/j.jocd.2018.06.008
|
| 22 |
Shirley Siang Ning Tan, Keng Tat Koh, Lee Len Tiong, Tiong Kiam Ong, Alan Yean Yip Fong.
Late Stent Thrombosis in a Patient With
CYP2C19*3/*17
Genotype and Clopidogrel High On-Treatment Platelet Reactivity
. Pharmacogenomics 2018; 19(15): 1151 doi: 10.2217/pgs-2018-0082
|
| 23 |
Tarun Girotra, Forrest Lowe, Wuwei Feng, Bruce Ovbiagele. Antiplatelet Agents in Secondary Stroke Prevention: Selection, Timing, and Dose. Current Treatment Options in Neurology 2018; 20(8) doi: 10.1007/s11940-018-0514-5
|
| 24 |
|
| 25 |
Danielle Duffy, Bridget Rooney, Suzanne Adams, David J Whellan. PA32540 for the secondary prevention of cardiovascular disease in patients at risk for aspirin-associated gastric ulcers. Expert Review of Cardiovascular Therapy 2014; 12(11): 1251 doi: 10.1586/14779072.2014.967214
|
| 26 |
James R. Butler, Tyrone Rogers, George Eckart, Gregory R. Martens, Eugene P. Ceppa, Michael G. House, Attila Nakeeb, C. Max Schmidt, Nicholas J. Zyromski. Is Antisecretory Therapy After Pancreatoduodenectomy Necessary? Meta-analysis and Contemporary Practices of Pancreatic Surgeons. Journal of Gastrointestinal Surgery 2015; 19(4): 604 doi: 10.1007/s11605-015-2765-8
|
| 27 |
|
| 28 |
Tommy Andersson, Peter Nagy, Mohammad Niazi, Sven Nylander, Hal Galbraith, Santosh Ranjan, Lars Wallentin. Effect of Esomeprazole With/Without Acetylsalicylic Acid, Omeprazole and Lansoprazole on Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Volunteers. American Journal of Cardiovascular Drugs 2014; 14(3): 217 doi: 10.1007/s40256-014-0073-4
|
| 29 |
Martin Klieber, Herbert Oberacher, Silvia Hofstaetter, Beate Beer, Martin Neururer, Anton Amann, Hannes Alber, Anil Modak. CYP2C19 Phenoconversion by Routinely Prescribed Proton Pump Inhibitors Omeprazole and Esomeprazole: Clinical Implications for Personalized Medicine. Journal of Pharmacology and Experimental Therapeutics 2015; 354(3): 426 doi: 10.1124/jpet.115.225680
|
| 30 |
Berit E.S. Jensen, Jane M. Hansen, Kasper S. Larsen, Anders B. Junker, Jens F. Lassen, Svend E. Jensen, Ove B. Schaffalitzky de Muckadell. Randomized clinical trial: the impact of gastrointestinal risk factor screening and prophylactic proton pump inhibitor therapy in patients receiving dual antiplatelet therapy. European Journal of Gastroenterology & Hepatology 2017; 29(10): 1118 doi: 10.1097/MEG.0000000000000934
|
| 31 |
Abdallah Damin Abukhalil, Tala Al Sheikh, Sandra Muallem, Ni'meh Al-Shami, Hani A Naseef. Prevalence and Safety of Prescribing PPIs with Clopidogrel in Palestine. Patient Preference and Adherence 2023; : 749 doi: 10.2147/PPA.S404139
|
| 32 |
Andrew J. Gawron, Joseph Feinglass, John E. Pandolfino, Bruce K. Tan, Michiel J. Bove, Stephanie Shintani-Smith. Brand Name and Generic Proton Pump Inhibitor Prescriptions in the United States: Insights from the National Ambulatory Medical Care Survey (2006–2010). Gastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/689531
|
| 33 |
Kristy Yuan, Anthony S. Kim. When a Single Antiplatelet Agent for Stroke Prevention Is Not Enough: Current Evidence and Future Applications of Dual Antiplatelet Therapy. Current Treatment Options in Cardiovascular Medicine 2016; 18(4) doi: 10.1007/s11936-016-0449-7
|
| 34 |
Jelmer E. Oor, David J. Roks, Joris A. Broeders, Eric J. Hazebroek, Hein G. Gooszen. Seventeen-year Outcome of a Randomized Clinical Trial Comparing Laparoscopic and Conventional Nissen Fundoplication. Annals of Surgery 2017; 266(1): 23 doi: 10.1097/SLA.0000000000002106
|